GHK-Cu: What the Copper Peptide Research Reports
A naturally occurring tripeptide that carries copper — collagen and matrix remodelling, the gene-expression literature, and why the vial is blue.
GHK-Cu is unusual among research peptides in that it is not synthetic in origin. It occurs naturally in human plasma, and the observation that its concentration falls with age is what drew research attention to it in the first place. This is what the published literature describes.
Everything below describes published preclinical and in-vitro research. It is not a therapeutic claim, not medical advice, and not a statement about effects in humans.
What it is
GHK is a tripeptide — glycyl-L-histidyl-L-lysine — that binds copper(II) with high affinity to form the complex written GHK-Cu. It was isolated from human plasma in the early 1970s, and reported plasma concentrations decline substantially between early adulthood and later life.
The copper is not incidental. Much of the published mechanism concerns the peptide acting as a copper carrier, delivering the ion to enzymes and transcription processes that require it. Studies describing GHK without copper generally report different behaviour, which is why the complex rather than the bare tripeptide is what appears in the research literature.
Reported mechanisms
- Collagen and extracellular matrix — the most frequently reported theme. Published work describes effects on collagen synthesis in fibroblast culture, alongside changes in the balance of matrix metalloproteinases and their inhibitors, which together govern matrix remodelling rather than deposition alone.
- Gene expression — a body of work using expression profiling reports that GHK-Cu modulates a large number of human genes, with the authors framing it as a resetting of expression toward a younger profile. This is the most cited and also the most cautiously read part of the literature.
- Angiogenesis — studies describing effects on vascular endothelial growth factor expression and capillary formation in wound models.
- Antioxidant behaviour — reported effects on superoxide dismutase activity and on iron-driven oxidative damage.
- Anti-inflammatory signalling — work describing suppression of pro-inflammatory cytokines in tissue models.
Why it appears in both repair and cosmetic research
The two literatures are the same mechanism observed at different scales. Matrix remodelling in a wound model and matrix remodelling in dermal research are the same underlying process, and GHK-Cu appears in both because collagen and MMP regulation are central to each.
That also explains the topical work: unlike most peptides in this catalog, a substantial part of the GHK-Cu literature concerns delivery through skin rather than solution work, and the two are not interchangeable in study design.
Practical notes
| Sequence | Gly-His-Lys, complexed with Cu(II) |
|---|---|
| Length | 3 amino acids |
| Appearance | Blue lyophilised powder |
| Primary reported mechanism | Copper delivery, matrix remodelling |
| Typical vial size | 50 mg |
The blue colour is worth knowing about: it comes from the copper complex and is expected. A GHK-Cu vial that arrives white is either not complexed or not what it claims to be, and this is one of the few compounds where appearance alone tells you something. It is not a substitute for the certificate, but it is a reasonable first look.
Reading this literature critically
- The gene-expression work is frequently cited well beyond what it establishes. Expression profiling describes what changed in a model system; it does not establish an outcome.
- A significant portion of the literature comes from a small number of groups, as is common in this field.
- Copper has its own biology and its own toxicity ceiling, so studies using the complex are not directly comparable to studies using the peptide alone.
- GHK-Cu is not an approved medicine in the European Union. Copper peptides do appear in cosmetic formulation, which is a separate regulatory category from what is sold here.
Handling and material quality
Supplied as lyophilised powder at 50 mg — a larger vial than most of the range, so check your concentration arithmetic rather than assuming the usual figures. Our reconstitution calculator handles it, and the reconstitution guide covers technique.
Every batch is analysed by an independent laboratory for HPLC purity and mass-spectrometric identity, with a batch-matched certificate available on request — and for a copper complex the identity confirmation is worth more than usual, since the mass tells you whether the copper is actually there.
See the GHK-Cu 50mg product page for full molecular data, or the rest of recovery and repair research.
All products and information referenced are for in-vitro research and laboratory use only. Nothing here is medical advice, and no therapeutic claim is made or implied.